Biblio

Export 497 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Keyword is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
J. Paulo Alme Santos, Vizuete, A., Hansen, F., Biasibetti, R., and Gonçalves, C. - A., Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 237-249, 2018.
C. Yang Santos, Lim, Y. Ying, Wu, W. - C., Machan, J. Timothy, Polynice, S., Schindler, R., Maruff, P., and Snyder, P. Jeffrey, Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-β and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 1, pp. 127-31, 2016.
H. Sandison, Callan, N. G. L., Rao, R. V., Phipps, J., and Bradley, R., Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline., J Alzheimers Dis, vol. 94, no. 3, pp. 993-1004, 2023.
C. Sanders, Behrens, S., Schwartz, S., Wengreen, H., Corcoran, C. D., Lyketsos, C. G., and Tschanz, J. A. T., Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1., J Alzheimers Dis, vol. 52, no. 1, pp. 33-42, 2016.
R. Sánchez-Valle, Monté, G. C., Sala-Llonch, R., Bosch, B., Fortea, J., Lladó, A., Antonell, A., Balasa, M., Bargalló, N., and Molinuevo, J. Luis, White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 827-35, 2016.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., Validation of the Spanish version of the Baylor Profound Mental Status Examination., J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
G. Sacco, Caillaud, C., Ben Sadoun, G., Robert, P., David, R., and Brisswalter, J., Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 1, pp. 19-25, 2016.
R
Z. Rusznák, Kim, W. Scott, Hsiao, J. - H. T., Halliday, G. M., Paxinos, G., and Fu, Y. H., Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb., J Alzheimers Dis, vol. 49, no. 2, pp. 443-57, 2016.
Z. Rusznák, Kim, W. Scott, Hsiao, J. - H. T., Halliday, G. M., Paxinos, G., and Fu, Y. H., Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb., J Alzheimers Dis, vol. 49, no. 2, pp. 443-57, 2016.
Z. Rusznák, Kim, W. Scott, Hsiao, J. - H. T., Halliday, G. M., Paxinos, G., and Fu, Y. H., Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb., J Alzheimers Dis, vol. 49, no. 2, pp. 443-57, 2016.
D. R. Royall, Palmer, R. F., Matsuoka, T., Kato, Y., Taniguchi, S., Ogawa, M., Fujimoto, H., Okamura, A., Shibata, K., Nakamura, K., Nakaaki, S., Koumi, H., Mimura, M., Fukui, K., and Narumoto, J., δ Scores are Exportable Across Cultural and Linguistic Boundaries., J Alzheimers Dis, vol. 49, no. 2, pp. 561-70, 2016.
D. R. Royall, Palmer, R. F., Matsuoka, T., Kato, Y., Taniguchi, S., Ogawa, M., Fujimoto, H., Okamura, A., Shibata, K., Nakamura, K., Nakaaki, S., Koumi, H., Mimura, M., Fukui, K., and Narumoto, J., Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data., J Alzheimers Dis, vol. 49, no. 2, pp. 571-9, 2016.
S. Aasish Roshan, Elangovan, G., Gunaseelan, D., Jayachandran, S. K., Kandasamy, M., and Anusuyadevi, M., Pathogenomic Signature and Aberrant Neurogenic Events in Experimental Cerebral Ischemic Stroke: A Neurotranscriptomic-Based Implication for Dementia., J Alzheimers Dis, vol. 94, no. s1, pp. S289-S308, 2023.
I. M. Rosa, Henriques, A. G., Wiltfang, J., and Silva, O. A. B. da Cru, Putative Dementia Cases Fluctuate as a Function of Mini-Mental State Examination Cut-Off Points., J Alzheimers Dis, vol. 61, no. 1, pp. 157-167, 2018.
M. Romeo, Stravalaci, M., Beeg, M., Rossi, A., Fiordaliso, F., Corbelli, A., Salmona, M., Gobbi, M., Cagnotto, A., and Diomede, L., Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity., J Alzheimers Dis, vol. 57, no. 3, pp. 857-871, 2017.
C. M. Roe, Babulal, G. M., Mishra, S., Gordon, B. A., Stout, S. H., Ott, B. R., Carr, D. B., Ances, B. M., Morris, J. C., and Benzinger, T. L. S., Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
M. Rodriguez-Perdigon, Solas, M., and Ramirez, M. Javier, JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 963-7, 2016.
J. M. Riphagen, van Egroo, M., and Jacobs, H. I. L., Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline., J Alzheimers Dis, vol. 80, no. 2, pp. 521-526, 2021.
J. M. Riphagen, van Egroo, M., and Jacobs, H. I. L., Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline., J Alzheimers Dis, vol. 80, no. 2, pp. 521-526, 2021.
J. Riancho, Pozueta, A., Santos, M., Lage, C., Carril, J. M., Banzo, I., Martínez-Rodriguez, I., Gorno-Tempini, M., and Sánchez-Juan, P., Logopenic Aphasia due to a Strategic Stroke: New Evidence from a Single Case., J Alzheimers Dis, vol. 57, no. 3, pp. 717-721, 2017.
H. F. M. Rhodius-Meester, Koikkalainen, J., Mattila, J., Teunissen, C. E., Barkhof, F., Lemstra, A. W., Scheltens, P., Lötjönen, J., and van der Flier, W. M., Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 261-70, 2016.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Page, R., Morrell, C., and Shea, T. B., Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study., J Alzheimers Dis, vol. 51, no. 4, pp. 991-5, 2016.
H. P Reddy, Manczak, M., Yin, X. L., Grady, M. Catherine, Mitchell, A., Tonk, S., Kuruva, C. Sekhar, Bhatti, J. Singh, Kandimalla, R., Vijayan, M., Kumar, S., Wang, R., Pradeepkiran, J. Adi, Ogunmokun, G., Thamarai, K., Quesada, K., Boles, A., and Reddy, A. P., Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests., J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.

Pages